Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody

Cell Research
Ying GuJ Sivaraman

Abstract

Hepatitis E virus (HEV), a non-enveloped, positive-sense, single-stranded RNA virus, is a major cause of enteric hepatitis. Classified into the family Hepeviridae, HEV comprises four genotypes (genotypes 1-4), which belong to a single serotype. We describe a monoclonal antibody (mAb), 8G12, which equally recognizes all four genotypes of HEV, with ∼ 2.53-3.45 nM binding affinity. The mAb 8G12 has a protective, neutralizing capacity, which can significantly block virus infection in host cells. Animal studies with genotypes 1, 3 and 4 confirmed the cross-genotype neutralizing capacity of 8G12 and its effective prevention of hepatitis E disease. The complex crystal structures of 8G12 with the HEV E2s domain (the most protruded region of the virus capsid) of the abundant genotypes 1 and 4 were determined at 4.0 and 2.3 Å resolution, respectively. These structures revealed that 8G12 recognizes both genotypes through the epitopes in the E2s dimerization region. Structure-based mutagenesis and cell-model assays with virus-like particles identified several conserved residues (Glu549, Lys554 and Gly591) that are essential for 8G12 neutralization. Moreover, the epitope of 8G12 is identified as a key epitope involved in virus-host interact...Continue Reading

References

Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
May 13, 1999·Bioinformatics·P GouetF Métoz
Feb 13, 2001·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S P JaiswalD S Chitnis
Mar 3, 2004·Acta Crystallographica. Section D, Biological Crystallography·Laurent C StoroniRandy J Read
Nov 24, 2004·The Journal of Biological Chemistry·Shao-Wei LiNing-Shao Xia
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jeffrey D BrowningHelen H Hobbs
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Aug 8, 2007·Journal of Molecular Biology·Evgeny Krissinel, Kim Henrick
Dec 20, 2007·The Journal of General Virology·Shuizhen HeNingshao Xia
Jan 15, 2008·Journal of Hepatology·R H Purcell, S U Emerson
May 30, 2008·Frontiers in Bioscience : a Journal and Virtual Library·Nicole PavioMarc Eloit
Jul 22, 2009·Proceedings of the National Academy of Sciences of the United States of America·Tetsuo YamashitaYoshiharu Matsuura
Jul 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Tom S Y GuuYizhi Jane Tao
Sep 4, 2009·The New England Journal of Medicine·Harry R DaltonSamreen Ijaz
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Mar 17, 2010·Journal of Molecular Biology·Johan FranssonJuan C Almagro
Aug 20, 2010·The Journal of Biological Chemistry·Li XingR Holland Cheng
Nov 12, 2010·Journal of Virology·Li XingR Holland Cheng
Jun 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Xuhua TangJ Sivaraman
Jul 9, 2011·Science·Damian C EkiertJaap Goudsmit
Sep 28, 2012·The New England Journal of Medicine·Jay H HoofnagleRobert H Purcell
Aug 21, 2013·Immunological Reviews·Barney S Graham
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor

❮ Previous
Next ❯

Citations

Jan 19, 2016·Expert Review of Vaccines·Xin WangQinjian Zhao
Jun 9, 2015·Vaccine·Zi-Min TangNing-Shao Xia
Apr 29, 2015·Current Opinion in Virology·Shaowei LiNingshao Xia
Mar 10, 2015·Human Vaccines & Immunotherapeutics·Xiao ZhangQinjian Zhao
May 18, 2016·Human Vaccines & Immunotherapeutics·Xing WuZhenglun Liang
Aug 23, 2016·Viruses·Xin YinZongdi Feng
Sep 23, 2016·Frontiers in Microbiology·Yuchen Nan, Yan-Jin Zhang
Mar 9, 2017·Human Vaccines & Immunotherapeutics·Xing WuZhenglun Liang
Apr 24, 2017·Medical Microbiology and Immunology·Osmany Larralde, Juraj Petrik
Dec 20, 2017·Frontiers in Microbiology·Yuchen NanEn-Min Zhou
Jun 22, 2018·Journal of Virology·Qingshan LinNingshao Xia
Dec 7, 2019·Human Vaccines & Immunotherapeutics·Kelei LiZhenglun Liang
Nov 7, 2019·Journal of Clinical Microbiology·Katrin BohmClaudia Sievers
Jan 30, 2020·Human Vaccines & Immunotherapeutics·Bin HeQinjian Zhao
Jun 1, 2017·Interdisciplinary Sciences, Computational Life Sciences·Lu XinNingshao Xia
Sep 2, 2020·Journal of Viral Hepatitis·Srinivas Reddy PallerlaThirumalaisamy P Velavan
Nov 17, 2017·Applied Microbiology and Biotechnology·Martynas SimanaviciusIndre Kucinskaite-Kodze
Apr 20, 2018·Proceedings of the National Academy of Sciences of the United States of America·Xin YinZongdi Feng
Dec 11, 2019·Proceedings of the National Academy of Sciences of the United States of America·Qingbing ZhengNingshao Xia
Oct 24, 2020·Pathogens·Srinivas Reddy PallerlaThirumalaisamy P Velavan
Oct 13, 2020·Trends in Immunology·Edem GavorJ Sivaraman
May 8, 2021·In Silico Pharmacology·Borris Rosnay Tietcheu GalaniPaul Fewou Moundipa
May 18, 2021·Computational and Structural Biotechnology Journal·Bo Wang, Xiang-Jin Meng
Oct 12, 2021·Applied Microbiology and Biotechnology·Beibei ZhangEn-Min Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

© 2021 Meta ULC. All rights reserved